On June 10, the U.S. International Trade Commission (ITC) made an affirmative vote in connection with the anti-dumping investigation of imports of methionine from France.
Notwithstanding this outcome, Adisseo said it remains committed to the U.S. market as a consistent and reliable supplier of methionine hydroxy-analogue. Unfortunately, the extremely restrictive nature of the tariffs on DL-methionine has forced Adisseo to exit this market segment, further limiting the choice of suppliers.
Adisseo said it is very disappointed with this decision, as it reduces the options available to U.S. purchasers for methionine. “The preliminary duties imposed by this investigation have already driven up cost substantially, cutting into margins for domestic animal protein producers, adding cost to the grocery bill for U.S. customers, and impacting the competitiveness of U.S. meat producers in export markets. Globally, Adisseo has proven to be a leader in methionine production, and continues to invest in new capacity & technology, to feed a growing planet,” the company said.
Adisseo is among the world leaders in animal nutrition with a turnover of 1.44 billion euros in 2019 and over 3,900 customers. The company’s mission is to feed the planet in a high-quality, affordable, safe and sustainable way. In 2006, Adisseo joined the Bluestar Group to gain access to other important markets in the global arena.